Skip to content
Search

Latest Stories

Loss of taste, smell key Covid-19 symptoms: UK Scientists

Losing your sense of smell and taste may be the best way to tell if you have Covid-19, according to a study of data collected via a symptom tracker app developed by British scientists to help monitor the pandemic caused by the new coronavirus.

Almost 60 per cent of patients who were subsequently confirmed as positive for Covid -19 had reported losing their sense of smell and taste, the data analysed by the researchers showed.


That compared with 18 per cent of those who tested negative.

These results, which were posted online but not peer-reviewed, were much stronger in predicting a positive Covid-19 diagnosis than self-reported fever, the researchers at King's College London said.

Of 1.5 million app users between March 24 and March 29, 26 per cent reported one or more symptoms through the app. Of these, 1,702 also reported having been tested for Covid-19, with 579 positive results and 1,123 negative results.

Using all the data collected, the research team developed a mathematical model to identify which combination of symptoms - ranging from loss of smell and taste, to fever, persistent cough, fatigue, diarrhoea, abdominal pain and loss of appetite -was most accurate in predicting Covid-19 infection.

"When combined with other symptoms, people with loss of smell and taste appear to be three times more likely to have contracted Covid-19 according to our data, and should therefore self-isolate for seven days to reduce the spread of the disease," said Tim Spector, a King's professor who led the study.

Spector's team applied their findings to the more than 400,000 people reporting symptoms via the app who had not yet had a Covid-19 test, and found that almost 13 per cent of them are likely to be infected.

This would suggest that some 50,000 people in Britain may have as yet unconfirmed Covid-19 infections, Spector said.

Official figures showed confirmed cases rose 14 per cent in Britain between Monday (30) and Tuesday (31) to 25,150 as of Tuesday at 0800 GMT.

The government said 1,789 people have died in hospitals from coronavirus as of 1600 GMT on Monday.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less